126 related articles for article (PubMed ID: 37524255)
1. Mechanically promoted lipid-based filaments via composition tuning for extrusion-based 3D-printing.
Abdelhamid M; Corzo C; Ocampo AB; Maisriemler M; Slama E; Alva C; Lochmann D; Reyer S; Freichel T; Salar-Behzadi S; Spoerk M
Int J Pharm; 2023 Aug; 643():123279. PubMed ID: 37524255
[TBL] [Abstract][Full Text] [Related]
2. Filament-based 3D-printing of placebo dosage forms using brittle lipid-based excipients.
Abdelhamid M; Koutsamanis I; Corzo C; Maisriemler M; Ocampo AB; Slama E; Alva C; Lochmann D; Reyer S; Freichel T; Salar-Behzadi S; Spoerk M
Int J Pharm; 2022 Aug; 624():122013. PubMed ID: 35839981
[TBL] [Abstract][Full Text] [Related]
3. Can filaments, pellets and powder be used as feedstock to produce highly drug-loaded ethylene-vinyl acetate 3D printed tablets using extrusion-based additive manufacturing?
Samaro A; Shaqour B; Goudarzi NM; Ghijs M; Cardon L; Boone MN; Verleije B; Beyers K; Vanhoorne V; Cos P; Vervaet C
Int J Pharm; 2021 Sep; 607():120922. PubMed ID: 34303815
[TBL] [Abstract][Full Text] [Related]
4. Low temperature fused deposition modeling (FDM) 3D printing of thermolabile drugs.
Kollamaram G; Croker DM; Walker GM; Goyanes A; Basit AW; Gaisford S
Int J Pharm; 2018 Jul; 545(1-2):144-152. PubMed ID: 29705104
[TBL] [Abstract][Full Text] [Related]
5. 3D printing of pharmaceutical oral solid dosage forms by fused deposition: The enhancement of printability using plasticised HPMCAS.
Oladeji S; Mohylyuk V; Jones DS; Andrews GP
Int J Pharm; 2022 Mar; 616():121553. PubMed ID: 35131354
[TBL] [Abstract][Full Text] [Related]
6. Development of modified release 3D printed tablets (printlets) with pharmaceutical excipients using additive manufacturing.
Goyanes A; Fina F; Martorana A; Sedough D; Gaisford S; Basit AW
Int J Pharm; 2017 Jul; 527(1-2):21-30. PubMed ID: 28502898
[TBL] [Abstract][Full Text] [Related]
7. Synergistic application of twin-screw granulation and selective laser sintering 3D printing for the development of pharmaceutical dosage forms with enhanced dissolution rates and physical properties.
Thakkar R; Zhang Y; Zhang J; Maniruzzaman M
Eur J Pharm Biopharm; 2021 Jun; 163():141-156. PubMed ID: 33838262
[TBL] [Abstract][Full Text] [Related]
8. Screening of pharmaceutical polymers for extrusion-Based Additive Manufacturing of patient-tailored tablets.
Samaro A; Janssens P; Vanhoorne V; Van Renterghem J; Eeckhout M; Cardon L; De Beer T; Vervaet C
Int J Pharm; 2020 Aug; 586():119591. PubMed ID: 32640268
[TBL] [Abstract][Full Text] [Related]
9. Adaptation of pharmaceutical excipients to FDM 3D printing for the fabrication of patient-tailored immediate release tablets.
Sadia M; Sośnicka A; Arafat B; Isreb A; Ahmed W; Kelarakis A; Alhnan MA
Int J Pharm; 2016 Nov; 513(1-2):659-668. PubMed ID: 27640246
[TBL] [Abstract][Full Text] [Related]
10. How to Obtain the Maximum Properties Flexibility of 3D Printed Ketoprofen Tablets Using Only One Drug-Loaded Filament?
Pyteraf J; Jamróz W; Kurek M; Szafraniec-Szczęsny J; Kramarczyk D; Jurkiewicz K; Knapik-Kowalczuk J; Tarasiuk J; Wroński S; Paluch M; Jachowicz R
Molecules; 2021 May; 26(11):. PubMed ID: 34067434
[TBL] [Abstract][Full Text] [Related]
11. Development of immediate release (IR) 3D-printed oral dosage forms with focus on industrial relevance.
Fanous M; Gold S; Hirsch S; Ogorka J; Imanidis G
Eur J Pharm Sci; 2020 Dec; 155():105558. PubMed ID: 32946957
[TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of hot-melt extruded polycaprolactone-based filaments intended for 3D-printing of tablets.
Viidik L; Vesala J; Laitinen R; Korhonen O; Ketolainen J; Aruväli J; Kirsimäe K; Kogermann K; Heinämäki J; Laidmäe I; Ervasti T
Eur J Pharm Sci; 2021 Mar; 158():105619. PubMed ID: 33115676
[TBL] [Abstract][Full Text] [Related]
13. Melt extrusion deposition (MED™) 3D printing technology - A paradigm shift in design and development of modified release drug products.
Zheng Y; Deng F; Wang B; Wu Y; Luo Q; Zuo X; Liu X; Cao L; Li M; Lu H; Cheng S; Li X
Int J Pharm; 2021 Jun; 602():120639. PubMed ID: 33901601
[TBL] [Abstract][Full Text] [Related]
14. Development of an immediate release excipient composition for 3D printing via direct powder extrusion in a hospital.
Rosch M; Gutowski T; Baehr M; Eggert J; Gottfried K; Gundler C; Nürnberg S; Langebrake C; Dadkhah A
Int J Pharm; 2023 Aug; 643():123218. PubMed ID: 37467818
[TBL] [Abstract][Full Text] [Related]
15. Can filaments be stored as a shelf-item for on-demand manufacturing of oral 3D printed tablets? An initial stability assessment.
Okwuosa TC; Sadia M; Isreb A; Habashy R; Peak M; Alhnan MA
Int J Pharm; 2021 May; 600():120442. PubMed ID: 33675925
[TBL] [Abstract][Full Text] [Related]
16. Hypromellose - A traditional pharmaceutical excipient with modern applications in oral and oromucosal drug delivery.
Mašková E; Kubová K; Raimi-Abraham BT; Vllasaliu D; Vohlídalová E; Turánek J; Mašek J
J Control Release; 2020 Aug; 324():695-727. PubMed ID: 32479845
[TBL] [Abstract][Full Text] [Related]
17. Preparation and investigation of novel gastro-floating tablets with 3D extrusion-based printing.
Li Q; Guan X; Cui M; Zhu Z; Chen K; Wen H; Jia D; Hou J; Xu W; Yang X; Pan W
Int J Pharm; 2018 Jan; 535(1-2):325-332. PubMed ID: 29051121
[TBL] [Abstract][Full Text] [Related]
18. Roadmap to 3D-Printed Oral Pharmaceutical Dosage Forms: Feedstock Filament Properties and Characterization for Fused Deposition Modeling.
Aho J; Bøtker JP; Genina N; Edinger M; Arnfast L; Rantanen J
J Pharm Sci; 2019 Jan; 108(1):26-35. PubMed ID: 30445005
[TBL] [Abstract][Full Text] [Related]
19. Role of release modifiers to modulate drug release from fused deposition modelling (FDM) 3D printed tablets.
Shi K; Salvage JP; Maniruzzaman M; Nokhodchi A
Int J Pharm; 2021 Mar; 597():120315. PubMed ID: 33540000
[TBL] [Abstract][Full Text] [Related]
20. Development of mechanistic models to identify critical formulation and process variables of pastes for 3D printing of modified release tablets.
Zidan A; Alayoubi A; Asfari S; Coburn J; Ghammraoui B; Aqueel S; Cruz CN; Ashraf M
Int J Pharm; 2019 Jan; 555():109-123. PubMed ID: 30453019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
